当前位置:首页 - 行情中心 - 天康生物(002100) - 财务分析

天康生物

(002100)

  

流通市值:90.52亿  总市值:90.52亿
流通股本:13.65亿   总股本:13.65亿

天康生物(002100)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润4.10亿元,每股收益0.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益860363.93万元,未分配利润122438.04万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1624248.69万元,负债763884.76万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入8,846,725,199.54,180,253,944.2417,175,805,190.1113,087,153,128.58
营业总成本8,435,393,584.634,012,088,136.816,479,483,378.2112,617,293,868.82
其他经营收益
营业利润403,950,602.49154,716,821.76631,109,922.65587,400,584.34
利润总额420,984,340.33172,533,576.51610,812,435.64571,988,017.46
净利润409,618,129.4171,441,542.03596,421,188.04554,495,769.58
每股收益
其他综合收益-25,190,790.19-41,188,202.22225,776.623,086,398.37
综合收益总额384,427,339.21130,253,339.81596,646,964.66557,582,167.95
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计8,776,473,163.5710,244,239,958.979,847,752,197.039,115,407,832.64
非流动资产:
非流动资产合计7,466,013,773.777,554,295,360.367,714,760,074.097,806,570,572.28
资产总计16,242,486,937.3417,798,535,319.3317,562,512,271.1216,921,978,404.92
流动负债:
流动负债合计5,543,641,728.366,700,619,328.216,494,865,978.896,162,799,255.8
非流动负债:
非流动负债合计2,095,205,873.482,448,092,689.212,548,093,652.42,278,766,530.69
负债合计7,638,847,601.849,148,712,017.429,042,959,631.298,441,565,786.49
所有者权益(或股东权益):
归属于母公司股东权益合计7,028,287,241.177,122,587,964.947,015,639,913.056,945,825,951.39
股东权益合计8,603,639,335.58,649,823,301.918,519,552,639.838,480,412,618.43
负债和股东权益合计16,242,486,937.3417,798,535,319.3317,562,512,271.1216,921,978,404.92
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计8,820,950,257.064,135,625,727.3818,713,785,052.9212,780,339,451.08
经营活动现金流出小计7,201,924,795.74,011,581,301.0817,551,919,746.610,634,872,485.63
经营活动产生的现金流量净额1,619,025,461.36124,044,426.31,161,865,306.322,145,466,965.45
投资活动产生的现金流量:
投资活动现金流入小计686,699.99055,443,797.1944,846,026.14
投资活动现金流出小计179,118,903.5172,139,359.2805,462,554.36597,843,758.01
投资活动产生的现金流量净额-178,432,203.52-72,139,359.2-750,018,757.17-552,997,731.87
筹资活动产生的现金流量:
筹资活动现金流入小计1,270,987,240.221,180,253,285.96,863,173,242.43,763,906,836.89
筹资活动现金流出小计2,855,507,964.661,107,466,510.026,994,042,341.074,546,799,823.71
筹资活动产生的现金流量净额-1,584,520,724.4472,786,775.88-130,869,098.67-782,892,986.82
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-143,927,466.6124,691,842.98280,977,450.48809,576,246.76
期末现金及现金等价物余额2,809,635,083.33,078,254,392.882,953,562,549.93,482,161,346.18
补充资料:
现金及现金等价物的净增加额-143,927,466.6-280,977,450.48-
最新报告期:2025-08-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券盛夏,彭家乐0.400.580.632025-08-27
TOP↑